Trials / Completed
CompletedNCT02024152
Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- JDP Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is to investigate the pharmacokinetics (PK) together with the safety and tolerability of JDP-205 at 5 mg and 10 mg intravenous doses and 10 mg intramuscular dose, in comparison to the marketed cetirizine oral product Zyrtec® 10 mg tablets (an OTC product) in healthy male and female volunteers after a single dose administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JDP-205 IV high dose | |
| DRUG | JDP-205 IV low dose | |
| DRUG | JDP-205 IM | |
| DRUG | Control: Zyrtec |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2013-12-31
- Last updated
- 2024-03-06
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02024152. Inclusion in this directory is not an endorsement.